The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / ACR Convergence

ACR Convergence

Get complete coverage of ACR Convergence 2022 here. Plus, explore our Gout, Axial Spondyloarthritis and Psoriatic Arthritis Resource Centers for research reviews, case reports and clinical articles on advances in the diagnosis and management of these conditions.

Focused Content

  • Gout Resource Center

    Explore our coverage of the top research and additional gout information presented at ACR Convergence 2021 and much more.

    [View]
  • Axial Spondyloarthritis Resource Center

    Chu KyungMin / shutterstock.com

    Explore our coverage of the top research in axial spondyloarthritis, additional information
    presented at ACR Convergence 2022 and much more.

    [View]
  • Psoriatic Arthritis in Focus

    Psoriatic Arthritis

    Explore our coverage of the top research in psoriatic arthritis and additional information presented at ACR Convergence 2022 and much more.

    [View]

Previous ACR Meetings

  • ACR Convergence 2021
  • ACR Convergence 2020
  • 2019 ACR/ARP Annual Meeting
  • 2018 ACR/ARHP Annual Meeting
  • 2017 ACR/ARHP Annual Meeting
  • 2016 ACR/ARHP Annual Meeting
  • 2015 ACR/ARHP Annual Meeting
  • 2014 ACR/ARHP Annual Meeting
  • 2011 ACR/ARHP Annual Meeting
  • 2010 ACR/ARHP Annual Scientific Meeting
  • 2006 ACR Annual Meeting
  • ACR/ARHP Annual Meeting
  • Annual Meeting

Complete Coverage

COVID-19: Strategies to Protect Adult & Pediatric Patients

An ACR Convergence 2022 session provided practical updates on ways to best protect pediatric & adult patients with rheumatic disease from COVID-19.... [Read More]

Patients Living with Chronic Illness

At ACR Convergence 2022, three women with rheumatic diseases discuss the profound life changes that the diseases wrought and ways they’ve found to cope.... [Read More]

Clinical Rheumatology Year in Review—2022

In this overview of clinical updates in rheumatology in the last year, high-impact studies were discussed, including the GLORIA, ORAL Surveillance and MIRROR trials.... [Read More]

A Shot of Wisdom: Vaccinations in Patients with Rheumatic Disease

PHILADELPHIA—The treatment of rheumatic diseases is often a double-edged sword: immunosuppressive regimens can be very effective in reducing disease activity, but the cost of such treatments may be seen in the form of increased risk of infection. At ACR Convergence 2022, the session titled ACR Guidelines for Vaccination in Patients with Rheumatic and Musculoskeletal Diseases… [Read More]

Patients Fight Against Dark Days & Find Ways to Cope

PHILADELPHIA—Amy Gietzen started feeling the pain when she was 19. Her forearms, elbows, wrists and fingers were constantly swollen and sensitive. Six months later, she saw a doctor and was diagnosed with systemic diffuse scleroderma—a particularly hard-to-manage rheumatic disease with wide-ranging effects. Ms. Gietzen, who spoke at ACR Convergence 2022 and is a public speaker,… [Read More]

Rheumatic Disease Research in Indigenous Populations

This ACR Convergence 2022 session focused on ways to improve health equity in Indigenous populations.... [Read More]

Evolution of Medicare’s Merit-Based Incentive Payment System: MIPS Value Pathways

In November, the CMS finalized 12 MIPS Value Pathways (MVP) in the Quality Payment Program, including a rheumatology MVP. In 2023, clinicians can opt to report via traditional MIPS, the rheumatology MVP or both.... [Read More]

Understaffed, Over-Scrutinized & Feeling Powerless? ACR Advocacy Can Help

Elizabeth “Blair” Solow, MD, MSc, and Angus Worthing, MD, FACP, FACR, described the top political issues affecting rheumatology now and how ACR members can work toward practices and policies that help us better care for patients.... [Read More]

Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel… [Read More]

New Findings for Polymyalgia Rheumatica & Osteoarthritis

The Plenary III Session reviewed the results of the SAPHYR trial of sarilumab in PMR patients, as well as the WE-CAN study on the impact of a community-level diet & exercise program on knee pain in patients with knee osteoarthritis.... [Read More]

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)